Distinguishing between indications for use of medications in administrative data sources application to pregabalin and gabapentin A contribution from the ConcePTION project
Anna‐Belle Beau(Inserm), Olga Paoletti(Agenzia Regionale di Sanità della Toscana), Joan K. Morris(St George's, University of London), R. Lassalle(Université de Bordeaux), Mika Gissler(Finnish Institute for Health and Welfare), Marco Manfrini(University of Padua), Angela Lupattelli(University of Oslo), Justine Bénevent(Université Toulouse III - Paul Sabatier), Maarit K. Leinonen(University of Helsinki), Xavier Moisset(Inserm), Rosa Gini(Agenzia Regionale di Sanità della Toscana), Sue Jordan(Swansea University), Visa Martikainen(Finnish Institute for Health and Welfare), Marie‐Agnès Bernard(Clinical Investigation Center Plurithematic Tours), Hedvig Nordeng(University of Oslo), Marie Beslay(Université Toulouse III - Paul Sabatier)
HAL (Le Centre pour la Communication Scientifique Directe)
January 1, 2023
Cited by 0
Related Papers
Randomized Trial of Preventive Angioplasty in Myocardial Infarction
|New England Journal of Medicine|2013|1k
Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials
|The American Journal of Medicine|2009|941
Association of Genetic and Environmental Factors With Autism in a 5-Country Cohort
|JAMA Psychiatry|2019|622
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study
|The Lancet Oncology|2017|510
Cardiovascular morbidity and mortality after orthotopic liver transplantation
|Transplantation|2002|326